Rating History for Poseida Therapeutics, Inc (PSTX) by Piper Sandler

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
12/2/2024 Edward Tenthoff Downgrade Neutral
(Overweight)
10.00
(N/A)
9.33
(9.50)
1.82% Details